AtriCure, Inc. (ATRC): Price and Financial Metrics

AtriCure, Inc. (ATRC): $46.91

-0.16 (-0.34%)

POWR Rating

Component Grades













ATRC Price/Volume Stats

Current price $46.91 52-week high $52.96
Prev. close $47.07 52-week low $32.51
Day low $46.58 Volume 170,400
Day high $47.66 Avg. volume 324,162
50-day MA $43.85 Dividend yield N/A
200-day MA $42.97 Market Cap 2.22B

ATRC Stock Price Chart Interactive Chart >


  • ATRC scores best on the Sentiment dimension, with a Sentiment rank ahead of 84.01% of US stocks.
  • The strongest trend for ATRC is in Sentiment, which has been heading up over the past 179 days.
  • ATRC's current lowest rank is in the Value metric (where it is better than 32.15% of US stocks).

ATRC Stock Summary

  • ATRC's price/sales ratio is 6.45; that's higher than the P/S ratio of 83.63% of US stocks.
  • ATRC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 17.37% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, ATRICURE INC is reporting a growth rate of -156%; that's higher than merely 10.25% of US stocks.
  • Stocks that are quantitatively similar to ATRC, based on their financial statements, market capitalization, and price volatility, are GENC, MDB, UMH, MSTR, and PATH.
  • ATRC's SEC filings can be seen here. And to visit ATRICURE INC's official web site, go to

ATRC Valuation Summary

  • In comparison to the median Healthcare stock, ATRC's EV/EBIT ratio is 694.17% lower, now standing at -71.3.
  • ATRC's price/sales ratio has moved down 9.6 over the prior 217 months.

Below are key valuation metrics over time for ATRC.

Stock Date P/S P/B P/E EV/EBIT
ATRC 2023-05-23 6.5 5.0 -60.2 -71.3
ATRC 2023-05-22 6.7 5.1 -61.7 -73.1
ATRC 2023-05-19 6.5 5.0 -60.4 -71.6
ATRC 2023-05-18 6.6 5.1 -61.2 -72.5
ATRC 2023-05-17 6.6 5.0 -60.8 -72.1
ATRC 2023-05-16 6.6 5.1 -61.3 -72.6

ATRC Growth Metrics

    The 2 year revenue growth rate now stands at 25.89%.
  • The 3 year price growth rate now stands at 82.01%.
  • Its year over year cash and equivalents growth rate is now at -67.04%.
Over the past 33 months, ATRC's revenue has gone up $84,762,000.

The table below shows ATRC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 315.569 -21.886 -56.037
2022-06-30 302.783 -20.334 53.343
2022-03-31 289.63 -29.096 51.933
2021-12-31 274.329 -13.78 50.199
2021-09-30 258.836 -10.127 45.378
2021-06-30 243.133 -6.083 -56.679

ATRC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATRC has a Quality Grade of C, ranking ahead of 28.8% of graded US stocks.
  • ATRC's asset turnover comes in at 0.344 -- ranking 124th of 186 Medical Equipment stocks.
  • INGN, BSX, and GKOS are the stocks whose asset turnover ratios are most correlated with ATRC.

The table below shows ATRC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.344 0.746 -0.169
2021-03-31 0.301 0.729 -0.142
2020-12-31 0.311 0.723 -0.152
2020-09-30 0.337 0.722 -0.163
2020-06-30 0.361 0.722 -0.213
2020-03-31 0.463 0.736 -0.227

ATRC Price Target

For more insight on analysts targets of ATRC, see our ATRC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $96.71 Average Broker Recommendation 1.31 (Strong Buy)

AtriCure, Inc. (ATRC) Company Bio

Atricure provides atrial fibrillation solutions worldwide. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The company was founded in 2000 and is based in West Chester, Ohio.

ATRC Latest News Stream

Event/Time News Detail
Loading, please wait...

ATRC Latest Social Stream

Loading social stream, please wait...

View Full ATRC Social Stream

Latest ATRC News From Around the Web

Below are the latest news stories about ATRICURE INC that investors may wish to consider to help them evaluate ATRC as an investment opportunity.

AtriCure First Quarter 2023 Earnings: Beats Expectations

AtriCure ( NASDAQ:ATRC ) First Quarter 2023 Results Key Financial Results Revenue: US$93.5m (up 25% from 1Q 2022). Net...

Yahoo | May 4, 2023

Q1 2023 AtriCure Inc Earnings Call

Q1 2023 AtriCure Inc Earnings Call

Yahoo | May 3, 2023

AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of 32.35% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 2, 2023

AtriCure Reports First Quarter 2023 Financial Results

MASON, Ohio, May 02, 2023--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced first quarter 2023 financial results.

Yahoo | May 2, 2023

AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

MASON, Ohio, April 19, 2023--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company will be hosting an investor education webcast in conjunction with Canaccord Genuity, focusing on Cryo Nerve Block Therapy. The company also announced that it will be participating in the upcoming 2023 Bank of America Health Care Conference.

Yahoo | April 19, 2023

Read More 'ATRC' Stories Here

ATRC Price Returns

1-mo 6.64%
3-mo 18.94%
6-mo 7.89%
1-year 11.48%
3-year -3.40%
5-year 93.28%
YTD 5.70%
2022 -36.17%
2021 24.90%
2020 71.24%
2019 6.24%
2018 67.76%

Continue Researching ATRC

Here are a few links from around the web to help you further your research on AtriCure Inc's stock as an investment opportunity:

AtriCure Inc (ATRC) Stock Price | Nasdaq
AtriCure Inc (ATRC) Stock Quote, History and News - Yahoo Finance
AtriCure Inc (ATRC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7515 seconds.